Condition: Non-Small Cell Carcinoma of Lung · Sponsor: Cantonal Hospital of St. Gallen
In the present study 'Fiber-Boost', we investigate how a high-fiber diet affects the immunotherapy of advanced lung cancer and what effects it has on the gut microbiome (i.e., the bacteria in the gut) as well as the immune system. Study participants will be assigned to either a test group or a control group. Only patients in the test group will undergo a high-fiber diet. The study lasts 6 weeks per patient and will be conducted at 4 centers within Switzerland. A total of 42 patients are planned to be included in the study.
This description comes directly from the study's public registry record.
Maximilian Boesch, Ph.D. · 0041714947143 · maximilian.boesch@h-och.ch
Always discuss trial participation with your own doctor first.
| Universitätsspital Basel | Basel, Switzerland | Not Yet Recruiting |
| Kantonsspital Graubünden | Chur, Switzerland | Not Yet Recruiting |
| HOCH Health Ostschweiz, Cantonal Hospital St.Gallen | Sankt Gallen, Switzerland | Recruiting |
| Kantonsspital Winterthur | Winterthur, Switzerland | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07483112